EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 1 filers reported holding EIDOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $59,513,000 | +152.6% | 452,295 | -3.0% | 0.72% | +66.9% |
| Q3 2020 | $23,557,000 | -16.8% | 466,205 | -21.5% | 0.43% | -17.4% |
| Q2 2020 | $28,308,000 | -16.2% | 593,842 | -13.9% | 0.52% | -44.8% |
| Q1 2020 | $33,778,000 | -16.1% | 689,478 | -1.7% | 0.95% | -1.7% |
| Q4 2019 | $40,241,000 | +21.2% | 701,178 | -24.0% | 0.96% | -13.3% |
| Q3 2019 | $33,200,000 | +21.6% | 923,003 | +5.1% | 1.11% | +43.7% |
| Q2 2019 | $27,301,000 | +36.7% | 878,403 | +3.1% | 0.77% | +32.1% |
| Q1 2019 | $19,977,000 | +70.1% | 851,900 | -0.2% | 0.58% | +23.9% |
| Q4 2018 | $11,744,000 | +35.6% | 853,500 | -1.6% | 0.47% | +77.4% |
| Q3 2018 | $8,660,000 | +122.9% | 867,700 | +354.3% | 0.27% | +101.5% |
| Q2 2018 | $3,885,000 | – | 191,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
| Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
| RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
| Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
| Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
| Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
| Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
| Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
| Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |